Skip to main content
Premium Trial:

Request an Annual Quote

Tataa Inks Distribution Deal for Yikon MALBAC Products

NEW YORK (GenomeWeb) — Tataa Biocenter has signed a deal to distribute and support Yikon Genomics' MALBAC single-cell whole-genome amplification products in Sweden, Norway, Germany, Austria, Slovakia , and the Czech Republic, the partners announced today. 

As part of the arrangement, Gothenburg, Sweden-based Tataa will also use the MALBAC technology in its next-generation sequencing training courses. Additional terms were not disclosed.

MALBAC, short for multiple annealing and looping-based amplification cycles, is designed to improve on the amount of genome that can be covered in whole genome amplification methods while also reducing amplification bias. It was developed by Harvard University's Sunney Xie. 

"We pioneered single cell transcriptomics over ten years ago and have the broadest product and services offerings in the field in Europe," Tataa CEO Mikael Kubista said in a statement. "Yikon's MALBAC technology … is a perfect complement to our current portfolio allowing us to offer also the best technology for single-cell genomics."

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.